Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Pediatric Brain Tumor Consortium phase 1 study of CD40 agonist sotigalimab in pediatric and young adult patients with recurrent CNS tumors and newly-diagnosed DIPG.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 13, 2026
A phase 2 PBTC study of selumetinib for recurrent/progressive pediatric low-grade glioma: Strata 2, 5, and 6 with long-term outcomes on strata 1, 3, and 4.
Journal: Neuro-oncology
Published: April 17, 2025
Establishing a Pediatric Health Equity, Diversity, and Inclusion Research Review Process.
Journal: Pediatrics
Published: February 12, 2024
Response assessment in pediatric craniopharyngioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) Working Group.
Journal: Neuro-oncology
Published: September 20, 2022
Joint EANM/SIOPE/RAPNO practice guidelines/SNMMI procedure standards for imaging of paediatric gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0.
Journal: European journal of nuclear medicine and molecular imaging
Published: February 07, 2022
Vorinostat and isotretinoin with chemotherapy in young children with embryonal brain tumors: A report from the Pediatric Brain Tumor Consortium (PBTC-026).
Journal: Neuro-oncology
Published: December 22, 2021
A Phase I and Surgical Study of Ribociclib and Everolimus in Children with Recurrent or Refractory Malignant Brain Tumors: A Pediatric Brain Tumor Consortium Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 16, 2020
Response assessment in diffuse intrinsic pontine glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.
Journal: The Lancet. Oncology
Published: December 20, 2019
Response assessment in paediatric low-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.
Journal: The Lancet. Oncology
Published: November 18, 2019
Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial.
Journal: The Lancet. Oncology
Published: February 06, 2019
MR Imaging-Based Radiomic Signatures of Distinct Molecular Subgroups of Medulloblastoma.
Journal: AJNR. American journal of neuroradiology
Published: June 29, 2018
A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study.
Journal: Neuro-oncology
Published: March 25, 2017
Last Updated: 09/26/2026